Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: John Zwiener who wrote (292)	3/17/1998 2:53:00 PM
From: James Perry	Read Replies (1) \| Respond to of 1025

Yes, I was referring to ABSC. Picked up some shares the other day, and as you mention, there is a hugh field out there. I appreciate your indication that there is no conflict between the research it is performing and that of Igen. Of course, I can get a sense that it may be on to a hot product, but I know too little to trust my own judgment. And I know too little to distinguish between the research of the two companies. But I trust John. When you said he had nibbled a bit, then I felt it was a worthwhile risk for me.

To: John Zwiener who wrote (292)	3/20/1998 8:14:00 PM
From: Ed Don	Respond to of 1025

I have owned Igen since it was 8,00 a share and still have a considerable position, I have noticed that from time to time other stocks have been mentioned on this board Back in Nov 1997 I mentioned Ortec ORTC) a company that seems to have a wound healing product superior to that of its competitors. Soros and other groups continue to accumulate the stock and own about 30%. Stock seems to have broken out in the last two days. It seems strange that the only response was posted under Gaylord Container.